GOP’s Rubio joins the pharma-bashing trend, slamming ‘profiteering’ on price hikes

Tracy Staton

The drug-pricing debate has moved to the Republican side of the aisle. GOP candidate Sen. Marco joined the fray in New Hampshire over the weekend, by "pure profiteering" by drugmakers that charge what the market will bear.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS